170 related articles for article (PubMed ID: 23064779)
1. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery?
Mariette C; Bruyère E; Messager M; Pichot-Delahaye V; Paye F; Dumont F; Brachet D; Piessen G;
Ann Surg Oncol; 2013 Apr; 20(4):1240-9. PubMed ID: 23064779
[TBL] [Abstract][Full Text] [Related]
2. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
3. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
[TBL] [Abstract][Full Text] [Related]
4. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
6. Is signet-ring cell carcinoma a specific entity among gastric cancers?
Voron T; Messager M; Duhamel A; Lefevre J; Mabrut JY; Goere D; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C; Paye F
Gastric Cancer; 2016 Oct; 19(4):1027-1040. PubMed ID: 26606931
[TBL] [Abstract][Full Text] [Related]
7. Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients.
Schmidt B; Look-Hong N; Maduekwe UN; Chang K; Hong TS; Kwak EL; Lauwers GY; Rattner DW; Mullen JT; Yoon SS
Ann Surg Oncol; 2013 Oct; 20(11):3512-8. PubMed ID: 23765416
[TBL] [Abstract][Full Text] [Related]
8. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
9. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery.
Badgwell B; Roy-Chowdhuri S; Chiang YJ; Matamoros A; Blum M; Fournier K; Mansfield P; Ajani J
J Surg Oncol; 2015 Jun; 111(7):875-81. PubMed ID: 25872485
[TBL] [Abstract][Full Text] [Related]
12. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
13. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
[TBL] [Abstract][Full Text] [Related]
16. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
17. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.
Messager M; Lefevre JH; Pichot-Delahaye V; Souadka A; Piessen G; Mariette C;
Ann Surg; 2011 Nov; 254(5):684-93; discussion 693. PubMed ID: 22005144
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of postoperative mortality after junctional and gastric adenocarcinoma resection.
Robb WB; Messager M; Goere D; Pichot-Delahaye V; Lefevre JH; Louis D; Guiramand J; Kraft K; Mariette C;
JAMA Surg; 2013 Jul; 148(7):624-31. PubMed ID: 23552982
[TBL] [Abstract][Full Text] [Related]
19. Does the surgical stress associated with palliative resection for patients with incurable gastric cancer with distant metastasis shorten their survival?
Moriwaki Y; Kunisaki C; Kobayashi S; Harada H; Imai S; Kasaoka C
Hepatogastroenterology; 2004; 51(57):872-5. PubMed ID: 15143937
[TBL] [Abstract][Full Text] [Related]
20. Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.
Okumura Y; Yamashita H; Aikou S; Yagi K; Yamagata Y; Nishida M; Mori K; Nomura S; Kitayama J; Watanabe T; Seto Y
World J Surg Oncol; 2014 Nov; 12():364. PubMed ID: 25432703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
